These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20176858)

  • 1. Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome.
    Phillips CM; Goumidi L; Bertrais S; Field MR; Cupples LA; Ordovas JM; Defoort C; Lovegrove JA; Drevon CA; Gibney MJ; Blaak EE; Kiec-Wilk B; Karlstrom B; Lopez-Miranda J; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    J Lipid Res; 2010 Jul; 51(7):1793-800. PubMed ID: 20176858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACC2 gene polymorphisms, metabolic syndrome, and gene-nutrient interactions with dietary fat.
    Phillips CM; Goumidi L; Bertrais S; Field MR; Cupples LA; Ordovas JM; McMonagle J; Defoort C; Lovegrove JA; Drevon CA; Blaak EE; Kiec-Wilk B; Riserus U; Lopez-Miranda J; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    J Lipid Res; 2010 Dec; 51(12):3500-7. PubMed ID: 20855566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome.
    Phillips CM; Goumidi L; Bertrais S; Field MR; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    J Nutr Biochem; 2012 Mar; 23(3):239-44. PubMed ID: 21543200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults.
    Phillips CM; Goumidi L; Bertrais S; Field MR; Ordovas JM; Cupples LA; Defoort C; Lovegrove JA; Drevon CA; Blaak EE; Gibney MJ; Kiec-Wilk B; Karlstrom B; Lopez-Miranda J; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    J Nutr; 2010 Feb; 140(2):238-44. PubMed ID: 20032477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome.
    Phillips CM; Goumidi L; Bertrais S; Ferguson JF; Field MR; Kelly ED; Peloso GM; Cupples LA; Shen J; Ordovas JM; McManus R; Hercberg S; Portugal H; Lairon D; Planells R; Roche HM
    Am J Clin Nutr; 2009 Dec; 90(6):1665-73. PubMed ID: 19828715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance.
    Ferguson JF; Phillips CM; Tierney AC; Pérez-Martínez P; Defoort C; Helal O; Lairon D; Planells R; Shaw DI; Lovegrove JA; Gjelstad IM; Drevon CA; Blaak EE; Saris WH; Leszczynska-Golabek I; Kiec-Wilk B; Risérus U; Karlström B; Miranda JL; Roche HM
    Am J Clin Nutr; 2010 Mar; 91(3):794-801. PubMed ID: 20032495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effect of polymorphisms in the IL-6, LTA, and TNF-{alpha} genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components.
    Phillips CM; Goumidi L; Bertrais S; Ferguson JF; Field MR; Kelly ED; Mehegan J; Peloso GM; Cupples LA; Shen J; Ordovas JM; McManus R; Hercberg S; Portugal H; Lairon D; Planells R; Roche HM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1386-94. PubMed ID: 20080841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-nutrient interactions and gender may modulate the association between ApoA1 and ApoB gene polymorphisms and metabolic syndrome risk.
    Phillips CM; Goumidi L; Bertrais S; Field MR; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    Atherosclerosis; 2011 Feb; 214(2):408-14. PubMed ID: 21122859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-nutrient interactions on the phosphoenolpyruvate carboxykinase influence insulin sensitivity in metabolic syndrome subjects.
    Perez-Martinez P; Garcia-Rios A; Delgado-Lista J; Gjelstad IM; Gibney J; Kieć-Wilk B; Camargo A; Helal O; Karlström B; Blaak EE; Hall W; Risérus U; Dembińska-Kieć A; Defoort C; Saris WH; Lovegrove JA; Drevon CA; Roche HM; Lopez-Miranda J
    Clin Nutr; 2013 Aug; 32(4):630-5. PubMed ID: 23092637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary saturated fat modulates the association between STAT3 polymorphisms and abdominal obesity in adults.
    Phillips CM; Goumidi L; Bertrais S; Field MR; Peloso GM; Shen J; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    J Nutr; 2009 Nov; 139(11):2011-7. PubMed ID: 19776189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dietary saturated fat intake accentuates obesity risk associated with the fat mass and obesity-associated gene in adults.
    Phillips CM; Kesse-Guyot E; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    J Nutr; 2012 May; 142(5):824-31. PubMed ID: 22457394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome--LIPGENE: a European randomized dietary intervention study.
    Tierney AC; McMonagle J; Shaw DI; Gulseth HL; Helal O; Saris WH; Paniagua JA; Gołąbek-Leszczyñska I; Defoort C; Williams CM; Karsltröm B; Vessby B; Dembinska-Kiec A; López-Miranda J; Blaak EE; Drevon CA; Gibney MJ; Lovegrove JA; Roche HM
    Int J Obes (Lond); 2011 Jun; 35(6):800-9. PubMed ID: 20938439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance determines a differential response to changes in dietary fat modification on metabolic syndrome risk factors: the LIPGENE study.
    Yubero-Serrano EM; Delgado-Lista J; Tierney AC; Perez-Martinez P; Garcia-Rios A; Alcala-Diaz JF; Castaño JP; Tinahones FJ; Drevon CA; Defoort C; Blaak EE; Dembinska-Kieć A; Risérus U; Lovegrove JA; Perez-Jimenez F; Roche HM; Lopez-Miranda J
    Am J Clin Nutr; 2015 Dec; 102(6):1509-17. PubMed ID: 26561628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucokinase regulatory protein genetic variant interacts with omega-3 PUFA to influence insulin resistance and inflammation in metabolic syndrome.
    Perez-Martinez P; Delgado-Lista J; Garcia-Rios A; Mc Monagle J; Gulseth HL; Ordovas JM; Shaw DI; Karlström B; Kiec-Wilk B; Blaak EE; Helal O; Malczewska-Malec M; Defoort C; Risérus U; Saris WH; Lovegrove JA; Drevon CA; Roche HM; Lopez-Miranda J
    PLoS One; 2011; 6(6):e20555. PubMed ID: 21674002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of CLOCK gene polymorphism rs1801260 in combination with low-fat diet on insulin metabolism in the patients with metabolic syndrome.
    Garcia-Rios A; Gomez-Delgado FJ; Garaulet M; Alcala-Diaz JF; Delgado-Lista FJ; Marin C; Rangel-Zuñiga OA; Rodriguez-Cantalejo F; Gomez-Luna P; Ordovas JM; Perez-Jimenez F; Lopez-Miranda J; Perez-Martinez P
    Chronobiol Int; 2014 Apr; 31(3):401-8. PubMed ID: 24328727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk.
    Phillips CM; Kesse-Guyot E; Ahluwalia N; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    Atherosclerosis; 2012 Feb; 220(2):513-9. PubMed ID: 22138144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin1beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome.
    Shen J; Arnett DK; Peacock JM; Parnell LD; Kraja A; Hixson JE; Tsai MY; Lai CQ; Kabagambe EK; Straka RJ; Ordovas JM
    J Nutr; 2007 Aug; 137(8):1846-51. PubMed ID: 17634253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gene variation (rs12691) in the CCAT/enhancer binding protein α modulates glucose metabolism in metabolic syndrome.
    Delgado-Lista J; Perez-Martinez P; Garcia-Rios A; Phillips CM; Hall W; Gjelstad IM; Lairon D; Saris W; Kieć-Wilk B; Karlström B; Drevon CA; Defoort C; Blaak EE; Dembinska-Kieć A; Risérus U; Lovegrove JA; Roche HM; Lopez-Miranda J
    Nutr Metab Cardiovasc Dis; 2013 May; 23(5):417-23. PubMed ID: 22269963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition.
    Li LO; Ellis JM; Paich HA; Wang S; Gong N; Altshuller G; Thresher RJ; Koves TR; Watkins SM; Muoio DM; Cline GW; Shulman GI; Coleman RA
    J Biol Chem; 2009 Oct; 284(41):27816-27826. PubMed ID: 19648649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOS3 gene polymorphisms are associated with risk markers of cardiovascular disease, and interact with omega-3 polyunsaturated fatty acids.
    Ferguson JF; Phillips CM; McMonagle J; Pérez-Martínez P; Shaw DI; Lovegrove JA; Helal O; Defoort C; Gjelstad IM; Drevon CA; Blaak EE; Saris WH; Leszczyńska-Gołabek I; Kiec-Wilk B; Risérus U; Karlström B; Lopez-Miranda J; Roche HM
    Atherosclerosis; 2010 Aug; 211(2):539-44. PubMed ID: 20409549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.